Skip to main content

Animations

MJFF Publications

2271 - 2280 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2017
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: Longitudinal analysis of impulse control disorders in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000005816
    Citation Count: 222
  • Summary Details
    OPEN
    Title: The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awy215
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-31988-0
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal data
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1006376
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0066-0
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0062-4
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0202201
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0184117
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Network connectivity determines cortical thinning in early Parkinson’s disease progression
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-017-02416-0
    Citation Count: 250
  • Summary Details
    OPEN
    Title: α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0494-9
    Citation Count: 156
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.